The Line on Your Blood Test That Predicts Mortality, and Why Nobody Reads It

Authors

The Peptide Dispatch Editorial Team

Summarized & reviewed by The Peptide Dispatch Editorial Team · Last reviewed August 3, 2026

TL;DR — Key Takeaways

Almost every blood panel drawn in the United States includes a complete blood count, and almost every complete blood count reports a value called RDW, or red cell distribution width. It sits in the middle of the results, usually between the hematocrit and the platelet count, expressed as a percentage somewhere in the low teens. It costs nothing extra. It is already paid for. It has been printed…

Overview

This dispatch covers The Line on Your Blood Test That Predicts Mortality, and Why Nobody Reads It in the metabolic research category, authored by The Peptide Dispatch Editorial Team. Estimated reading time: 9 minutes. The Peptide Dispatch curates peer-reviewed peptide research for self-directed learners. All summaries are presented for Research Use Only and do not constitute medical advice.

Abstract

Almost every blood panel drawn in the United States includes a complete blood count, and almost every complete blood count reports a value called RDW, or red cell distribution width. It sits in the middle of the results, usually between the hematocrit and the platelet count, expressed as a percentage somewhere in the low teens. It costs nothing extra. It is already paid for. It has been printed on lab reports for decades. And in most clinical encounters it is glanced at only when the hemoglobin is low, because that is what it was originally put there to do. If the hemoglobin is normal, the RDW is generally treated as noise. The research literature has been saying something different for close to twenty years. Across very large general-population cohorts, RDW tracks all-cause mortality with a consistency that most purpose-built risk markers do not achieve. What follows is what the published evidence actually reports, including the substantial parts of it that remain unexplained. What the number is measuring Red blood cells are supposed to be uniform. A healthy bone marrow producing cells under stable conditions turns out a population of erythrocytes that are close to the same size as one another. RDW quantifies how much they vary. It is a coefficient of variation of red cell volume, so a low value means the cells are tightly clustered around one size and a higher value means the population is spread out. The old clinical term for that spread is anisocytosis. On most US lab reports the reference range runs roughly 11.5 to 14.5 percent, though the exact interval depends on the analyzer, so the printed range on your own report is the one that applies. The reason it was added to the standard panel is diagnostic rather than prognostic. Iron deficiency produces small cells of uneven size, so it raises RDW early. Vitamin B12 and folate deficiency produce large cells. In a patient who is already anemic, RDW helps sort out which kind of anemia is present. That is a narrow…

More from the Research Library

• FDA Advisory Panel Backs 6 of 7 Peptides for Compounding — What the July 23–24 Vote Actually Changes — General
• Your Testosterone Result Is a Number About a Protein You Have Never Heard Of — metabolic
• Your Kidney Function Has Two Different Answers, and the Gap Between Them Predicts Mortality — metabolic
• Your Magnesium Test Is Measuring the Wrong 1 Percent — research
• Your Blood Is a Grease Report — And the One Fat Ratio That Predicts How Long You Live Isn't on Your Panel — research
• Your Cholesterol Is Fine and You Could Still Be on Fire Inside — The Inflammation Marker Almost No One Measures — research

Educational content — not medical advice. Effects described are drawn from cited research in study subjects.